Please login to the form below

Not currently logged in
Email:
Password:

Enterprise Therapeutics

This page shows the latest Enterprise Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Latest Intelligence

  • A snapshot of… Enterprise Therapeutics A snapshot of… Enterprise Therapeutics

    In this month’s issue of PME, we take a look at Enterprise Therapeutics and talk to CEO Dr John Ford about the company’s technologies and the obstacles it faces ... Enterprise Therapeutics is discovering and developing new therapies that target the

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Enterprise Therapeutics appoints CEO Enterprise Therapeutics appoints CEO

    Dr John Ford will lead the UK drug discovery company. Brighton, UK-based respiratory diseases specialist Enterprise Therapeutics has appointed Dr John Ford as chief executive officer, with immediate effect. ... Discovery. Dr Peter Finan, chairman of

  • Caldan Therapeutics bolsters senior team Caldan Therapeutics bolsters senior team

    Caldan Therapeutics, a subsidiary of the Universities of Glasgow and Southern Denmark, has made four new appointments to its senior management team. ... Dr Boyd currently serves as chief financial officer at private life sciences companies Oxford

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 700 experts delivering world-class...

Latest intelligence

Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...
Harness the power of data to map new patient pathways
Oli Hudson, of Wilmington Healthcare, explains why pharma needs to put data at the heart of its bid to support the NHS Reset...

Infographics